These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 17130531)

  • 41. PSMD9 gene variants within NIDDM2 may rarely contribute to type 2 diabetes.
    Gragnoli C; Cronsell J
    J Cell Physiol; 2007 Sep; 212(3):568-71. PubMed ID: 17516568
    [TBL] [Abstract][Full Text] [Related]  

  • 42. STAT4: a risk factor for type 1 diabetes?
    Zervou MI; Mamoulakis D; Panierakis C; Boumpas DT; Goulielmos GN
    Hum Immunol; 2008 Oct; 69(10):647-50. PubMed ID: 18703106
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential IL-21 signaling in APCs leads to disparate Th17 differentiation in diabetes-susceptible NOD and diabetes-resistant NOD.Idd3 mice.
    Liu SM; Lee DH; Sullivan JM; Chung D; Jäger A; Shum BO; Sarvetnick NE; Anderson AC; Kuchroo VK
    J Clin Invest; 2011 Nov; 121(11):4303-10. PubMed ID: 22019586
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic association of the neuropilin-1 gene with type 1 diabetes in children: Neuropilin-1 expression in pancreatic islets.
    Hasan NM; Kendrick MA; Druckenbrod NR; Huelsmeyer MK; Warner TF; MacDonald MJ
    Diabetes Res Clin Pract; 2010 Mar; 87(3):e29-32. PubMed ID: 20053475
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association between polymorphisms in IL21 gene and risk for sepsis.
    Miao T; Pu Y; Zhou B; Chen P; Wang Y; Song Y; Zhao J; Zhang L
    Biomarkers; 2017 Feb; 22(1):14-18. PubMed ID: 27295539
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vivo RNA interference demonstrates a role for Nramp1 in modifying susceptibility to type 1 diabetes.
    Kissler S; Stern P; Takahashi K; Hunter K; Peterson LB; Wicker LS
    Nat Genet; 2006 Apr; 38(4):479-83. PubMed ID: 16550170
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of a nuclear-factor-kappa B (NFkappaB) genetic marker in type 1 diabetes (T1DM) families.
    Gylvin T; Bergholdt R; Nerup J; Pociot F
    Genes Immun; 2002 Nov; 3(7):430-2. PubMed ID: 12424626
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lack of association between IL27 gene variants and type 1 diabetes susceptibility.
    Santos AS; Melo ME; Crisóstomo LG; Fukui RT; Matioli SR; Silva ME
    Cytokine; 2013 Feb; 61(2):349-52. PubMed ID: 23294976
    [TBL] [Abstract][Full Text] [Related]  

  • 49. VDR gene polymorphism at exon 2 start codon (FokI) may have influenced Type 1 diabetes mellitus susceptibility in two Spanish populations.
    Audí L; Martí G; Esteban C; Oyarzabal M; Chueca M; Gussinyé M; Yeste D; Fernández-Cancio M; Andaluz P; Carrascosa A
    Diabet Med; 2004 Apr; 21(4):393-4. PubMed ID: 15049946
    [No Abstract]   [Full Text] [Related]  

  • 50. Assessing the validity of the association between the SUMO4 M55V variant and risk of type 1 diabetes.
    Park Y; Park S; Kang J; Yang S; Kim D
    Nat Genet; 2005 Feb; 37(2):112; author reply 112-3. PubMed ID: 15678137
    [No Abstract]   [Full Text] [Related]  

  • 51. Linking the circadian rhythm gene Arntl2 to interleukin 21 expression in type 1 diabetes.
    Lebailly B; He C; Rogner UC
    Diabetes; 2014 Jun; 63(6):2148-57. PubMed ID: 24520124
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Loss of parity between IL-2 and IL-21 in the NOD Idd3 locus.
    McGuire HM; Vogelzang A; Hill N; Flodström-Tullberg M; Sprent J; King C
    Proc Natl Acad Sci U S A; 2009 Nov; 106(46):19438-43. PubMed ID: 19880748
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The functional variant -169C/T in the FCRL3 gene does not increase susceptibility to Type 1 diabetes.
    Turunen JA; Wessman M; Kilpikari R; Parkkonen M; Forsblom C; Groop PH;
    Diabet Med; 2006 Aug; 23(8):925-7. PubMed ID: 16911635
    [No Abstract]   [Full Text] [Related]  

  • 54. [Predictive medicine].
    Bach JF
    Bull Mem Acad R Med Belg; 1996; 151(1):115-21; discussion 121-3. PubMed ID: 8963255
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Protective and susceptibility effects of hSKCa3 allelic variants on juvenile myoclonic epilepsy.
    Vijai J; Kapoor A; Ravishankar HM; Cherian PJ; Kuruttukulam G; Rajendran B; Sridharan R; Rangan G; Girija AS; Jayalakshmi S; Mohandas S; Mani KS; Radhakrishnan K; Anand A
    J Med Genet; 2005 May; 42(5):439-42. PubMed ID: 15863675
    [No Abstract]   [Full Text] [Related]  

  • 56. [Genetic susceptibility to type 1 diabetes].
    Babaya N; Ikegami H
    Nihon Rinsho; 2012 May; 70 Suppl 3():337-41. PubMed ID: 22768543
    [No Abstract]   [Full Text] [Related]  

  • 57. [Correlation between 21st century COE of Center for Frontier Research Education on Lifestyle-Related Disease based on the large-scale cohort study and Kyushu University Hospital].
    Nawata H
    Fukuoka Igaku Zasshi; 2004 Oct; 95(10):253. PubMed ID: 15678881
    [No Abstract]   [Full Text] [Related]  

  • 58. Identification of nonsynonymous polymorphisms in the superantigen-coding region of IDDMK1,2 22 and a pilot study on the association between IDDMK1,2 22 and type 1 diabetes.
    Kinjo Y; Matsuura N; Yokota Y; Ohtsu S; Nomoto K; Komiya I; Sugimoto J; Jinno Y; Takasu N
    J Hum Genet; 2001; 46(12):712-6. PubMed ID: 11776384
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Japanese type 1 diabetic syndrome.
    Kawasaki E; Nagataki S
    Diabetes Metab Rev; 1996 Oct; 12(3):175-94. PubMed ID: 8959384
    [No Abstract]   [Full Text] [Related]  

  • 60. Novartis goes public with DNA data in bid to tackle diabetes.
    Knight J
    Nature; 2004 Oct; 431(7012):1029. PubMed ID: 15510115
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.